Cargando…
Development of and Access to Products for Neglected Diseases
INTRODUCTION: Prior research on neglected disease drug development suggested inadequate funding was responsible for relatively few new approvals. In response, significantly more resources have been allocated towards development of drugs targeting neglected diseases. Our objective was to reassess dru...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868904/ https://www.ncbi.nlm.nih.gov/pubmed/20485552 http://dx.doi.org/10.1371/journal.pone.0010610 |